Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Effect of Catheter Protector on Catheter Dwell Time and Complications

NCT: NCT06675786 · COMPLETED

NCT IDNCT06675786
StatusCOMPLETED
Start Date2024-10-15
Completion2025-05-22
SponsorKaramanoğlu Mehmetbey University (OTHER)
First posted
Last updated

Brief Summary

This study assessed the impact of IV House UltraDressing on PIVC dwell time and related complications in adult oncology patients.Adults hospitalised on an oncology ward between October 15, 2024 and May 22, 2025 were randomly allocated to an intervention group (transparent dressing plus IV House UltraDressing) or a control group (transparent dressing only). Data were collected using descriptive and catheter monitoring forms, and phlebitis was assessed using a 0-4 grading system.Outcomes included catheter dwell time, complication-related removals, and the distribution of non-infectious complications.

Frequently Asked Questions

What is The Effect of Catheter Protector on Catheter Dwell Time and Complications?

The Effect of Catheter Protector on Catheter Dwell Time and Complications is a clinical trial registered under NCT06675786. Current status: COMPLETED.

What is the status of NCT06675786?

The current status of NCT06675786 (The Effect of Catheter Protector on Catheter Dwell Time and Complications) is: COMPLETED.

When did The Effect of Catheter Protector on Catheter Dwell Time and Complications start?

The Effect of Catheter Protector on Catheter Dwell Time and Complications started on 2024-10-15.

Related Devices

K163513Arrow Endurance Extended Dwell Peripheral Catheter SystemArrow International, Inc. (Subsidiary of Teleflex, Inc.) K221057Viatrac 14 Plus Peripheral Dilatation CatheterAbbott Vascular K242281Arrow Endurance Extended Dwell Peripheral Catheter System (EDC-00620); Arrow Endurance Extended Dwell Peripheral Catheter System (EDC-00622); Arrow Endurance Extended Dwell Peripheral Catheter System (EDC-00820); Arrow Endurance Extended Dwell Peripheral Catheter System (EDC-00822)Arrow International, LLC (A subsidiary of Teleflex, Inc.) K243599Arrow™ Endurance™ Extended Dwell Peripheral Catheter System (EDC-00818)Arrow International, LLC (A subsidiary of Teleflex, Inc.)

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑